Pharmanutra Statistics

Total Valuation

Pharmanutra has a market cap or net worth of EUR 502.86 million. The enterprise value is 509.65 million.

Market Cap	502.86M
Enterprise Value	509.65M

Important Dates

The next estimated earnings date is Monday, September 9, 2024.

Earnings Date	Sep 9, 2024
Ex-Dividend Date	May 6, 2024

Share Statistics

Pharmanutra has 9.61 million shares outstanding.

Shares Outstanding	9.61M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.66%
Owned by Institutions (%)	15.13%
Float	4.28M

Valuation Ratios

The trailing PE ratio is 46.80 and the forward PE ratio is 29.22.

PE Ratio	46.80
Forward PE	29.22
PS Ratio	5.01
PB Ratio	8.94
P/FCF Ratio	329.75
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.30, with an EV/FCF ratio of 334.20.

EV / Earnings	47.07
EV / Sales	5.04
EV / EBITDA	21.30
EV / EBIT	24.15
EV / FCF	334.20

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 49.80.

Current Ratio	2.15
Quick Ratio	1.66
Debt / Equity	49.80
Debt / EBITDA	1.19
Debt / FCF	18.62
Interest Coverage	20.98

Financial Efficiency

Return on equity (ROE) is 19.37% and return on invested capital (ROIC) is 16.66%.

Return on Equity (ROE)	19.37%
Return on Assets (ROA)	11.99%
Return on Capital (ROIC)	16.66%
Revenue Per Employee	911,117
Profits Per Employee	97,550
Employee Count	111
Asset Turnover	0.92
Inventory Turnover	6.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.21% in the last 52 weeks. The beta is 0.31, so Pharmanutra's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-4.21%
50-Day Moving Average	48.78
200-Day Moving Average	53.46
Relative Strength Index (RSI)	60.86
Average Volume (20 Days)	4,136

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharmanutra had revenue of EUR 101.13 million and earned 10.83 million in profits. Earnings per share was 1.12.

Revenue	101.13M
Gross Profit	47.99M
Operating Income	21.10M
Pretax Income	21.00M
Net Income	10.83M
EBITDA	23.40M
EBIT	21.10M
Earnings Per Share (EPS)	1.12

Balance Sheet

The company has 21.61 million in cash and 28.39 million in debt, giving a net cash position of -6.78 million or -0.71 per share.

Cash & Cash Equivalents	21.61M
Total Debt	28.39M
Net Cash	-6.78M
Net Cash Per Share	-0.71
Equity (Book Value)	57.01M
Book Value Per Share	5.85
Working Capital	33.47M

Cash Flow

In the last 12 months, operating cash flow was 11.92 million and capital expenditures -10.40 million, giving a free cash flow of 1.53 million.

Operating Cash Flow	11.92M
Capital Expenditures	-10.40M
Free Cash Flow	1.53M
FCF Per Share	0.16

Margins

Gross margin is 47.45%, with operating and profit margins of 20.86% and 10.71%.

Gross Margin	47.45%
Operating Margin	20.86%
Pretax Margin	20.76%
Profit Margin	10.71%
EBITDA Margin	23.13%
EBIT Margin	20.86%
FCF Margin	1.51%

Dividends & Yields

This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 1.60%.

Dividend Per Share	0.85
Dividend Yield	1.60%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	71.24%
Buyback Yield	n/a
Shareholder Yield	1.60%
Earnings Yield	2.14%
FCF Yield	0.30%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a